Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial.
Clin Cancer Res
; 27(18): 5020-5027, 2021 09 15.
Article
in En
| MEDLINE
| ID: mdl-34253578
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Peptides
/
Antineoplastic Combined Chemotherapy Protocols
/
Leucovorin
/
Carcinoma, Pancreatic Ductal
/
Antibodies, Monoclonal, Humanized
/
Fluorouracil
/
Irinotecan
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2021
Document type:
Article
Country of publication:
United States